Related references
Note: Only part of the references are listed.Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
Pei-Hsuan Chen et al.
MOLECULAR CELL (2019)
In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
Milica Momcilovic et al.
NATURE (2019)
Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT
Hye Ryeong Kwon et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
Kyoichi Kaira et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms
Joyce C. Mhlanga et al.
NUCLEAR MEDICINE COMMUNICATIONS (2018)
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Tina Cascone et al.
CELL METABOLISM (2018)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
Pembrolizumab (pembro) versus platinum-based chemotherapy (chemo) as first-line therapy for advanced/metastatic NSCLC with a PD-L1 tumor proportion score (TPS) >= 1%: Open-label, phase 3 KEYNOTE-042 study.
Gilberto Lopes et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
Ross A. Soo et al.
Oncotarget (2018)
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
Edwin R. Parra et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC
David R. Spigel et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
H. Kadara et al.
ANNALS OF ONCOLOGY (2017)
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival
Haizhen Wang et al.
NATURE (2017)
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers
Monique B. Nilsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
Justin Goodwin et al.
NATURE COMMUNICATIONS (2017)
Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment
Kathrin Renner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
Haidong Tang et al.
CANCER CELL (2016)
Upregulated Glucose Metabolism Correlates Inversely with CD8+ T-cell Infiltration and Survival in Squamous Cell Carcinoma
Christian H. Ottensmeier et al.
CANCER RESEARCH (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response
Kerstin N. Timm et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Carlos Alfaro et al.
CLINICAL CANCER RESEARCH (2016)
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
Edwin R. Parra et al.
CLINICAL CANCER RESEARCH (2016)
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery
Egesta Lopci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis
Jing Liu et al.
PLOS ONE (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2
Robert J. G. Cardnell et al.
CLINICAL CANCER RESEARCH (2015)
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs et al.
NATURE CELL BIOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2015)
RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling
Juan Liu et al.
ONCOTARGET (2015)
nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)
Alessandra Cesano
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis
Hyung-Jun Im et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
Relationship Between 18F-FDG Accumulation and Lactate Dehydrogenase A Expression in Lung Adenocarcinomas
Xiang Zhou et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
Kyoungjune Pak et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer
Kyoichi Kaira et al.
LUNG CANCER (2014)
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Veronica Estrella et al.
CANCER RESEARCH (2013)
A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients
Hao Tang et al.
CLINICAL CANCER RESEARCH (2013)
18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
Edwin A. Usmanij et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
Alicia S. Chung et al.
NATURE MEDICINE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
WHAT IS THE BEST WAY TO CONTOUR LUNG TUMORS ON PET SCANS? MULTIOBSERVER VALIDATION OF A GRADIENT-BASED METHOD USING A NSCLC DIGITAL PET PHANTOM
Maria Werner-Wasik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
RAPID DISEASE PROGRESSION WITH DELAY IN TREATMENT OF NON-SMALL-CELL LUNG CANCER
Nasiruddin Mohammed et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
Kellie A. Charles et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
Kaiyumars B. Contractor et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
PET/CT imaging of lung cancer
John F. Bruzzi et al.
JOURNAL OF THORACIC IMAGING (2006)
[18F]FDG uptake and PCNA, glut-1, and hexokinase-II expressions in ccancers and inflammatory lesions of the lung
M Mamede et al.
NEOPLASIA (2005)
Share Paper
